News for Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma Announces That PRP Suppresses TGF-β Pathway & Tumor Microenvironment in Pancreatic Cancer

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Down 30.6% in October at ETF Daily News

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Sees Significant Growth in Short Interest at ETF Daily News

Read Satsuma Pharmaceuticals (NASDAQ:STSA) and Propanc Biopharma (OTCMKTS:PPCB) Head-To-Head Survey at ETF Daily News

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Up 113.3% in June at ETF Daily News

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Update at ETF Daily News

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Sees Significant Growth in Short Interest at ETF Daily News

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Sees Significant Decline in Short Interest at ETF Daily News

Read Propanc Biopharma, Inc. (OTCMKTS:PPCB) Short Interest Update at ETF Daily News